Anterior Segment Dysgenesis, Aniridia and Congenital Corneal Opacity
Key Takeaways
Posterior embryotoxon alone does not diagnose Axenfeld–Rieger syndrome or glaucoma.
Congenital opacity assessment includes corneal size, pressure, lens, iris and posterior potential.
Aniridia affects multiple ocular tissues; baseline foveal hypoplasia may limit acuity.
PAX6/WT1 contiguous deletions require systemic assessment distinct from isolated PAX6 disease.
A congenital opacity is a whole-eye problem
Congenital corneal opacity can result from developmental dysgenesis, endothelial dysfunction, glaucoma, birth trauma, infection or metabolic disease. Establish whether the opacity is unilateral or bilateral and central or diffuse, then assess corneal size, pressure, iris and lens anatomy and posterior visual potential. Dense opacity can obscure several structures at once. Ultrasound biomicroscopy and posterior ultrasound can help define hidden anatomy, with examination under anaesthesia selected when an adequate assessment is otherwise impossible.
Anterior segment development depends on coordinated surface ectoderm, neuroectoderm and periocular mesenchyme. An abnormal cornea can coexist with iris abnormalities and an abnormal drainage angle. A clear area sufficient for fixation may permit optical and amblyopia treatment without immediate transplantation; a visually obstructing opacity may require earlier intervention. Graft surgery in infants carries substantial rejection, glaucoma and amblyopia burdens, so clearing the cornea alone does not guarantee useful vision.
Peters anomaly and related opacity
Peters anomaly typically has a central corneal opacity with abnormal posterior stroma, Descemet membrane and endothelium, often with iridocorneal adhesions. Some eyes have lens involvement or lenticulocorneal adhesion. Assess the extent and associated glaucoma, microphthalmia or posterior anomalies rather than predicting prognosis from the name alone. The term Peters-plus refers to a syndromic phenotype and should not be used for every severe Peters eye.
Sclerocornea describes scleral-like opacity and vascularisation extending into the cornea, often with poorly defined limbal boundaries. Congenital hereditary endothelial dystrophy causes diffuse corneal oedema and clouding, usually without the pressure-related enlargement of primary congenital glaucoma. Forceps-related Descemet breaks and congenital glaucoma can both cause oedema, but their orientation, size and pressure context differ. Do not assume that a normal pressure recorded late during anaesthesia excludes earlier glaucoma.
| Pattern | Useful clue | Further assessment |
|---|---|---|
| Central opacity with iris adhesions | Peters-type developmental anomaly | Lens, angle, pressure and systemic phenotype |
| Peripheral scleralisation with indistinct limbus | Sclerocornea | Corneal extent and associated globe anomalies |
| Diffuse oedema in normally sized eyes | Endothelial disease possible | Pressure, family history and genetic assessment |
| Enlarged hazy cornea | Pressure-related stretching possible | Glaucoma examination and serial growth |
Axenfeld–Rieger spectrum
A prominent anteriorly displaced Schwalbe line is termed posterior embryotoxon. It can occur in otherwise normal eyes and is not itself a diagnosis of glaucoma. In Axenfeld–Rieger spectrum, additional findings include iris strands to the angle, iris hypoplasia, corectopia or pseudopolycoria. Glaucoma may emerge at different ages, requiring longitudinal assessment rather than only an infant pressure check.
FOXC1 and PITX2 are important associated genes, but the phenotype is genetically heterogeneous. Dental, umbilical, craniofacial and other systemic features guide examination and referral. Avoid assuming every patient shares one gene-specific systemic phenotype. The original FOXC1/PITX2 family study documents variable glaucoma presentation and supports ongoing monitoring. Genetic testing refines counselling but does not replace clinical pressure and nerve assessment.
Aniridia is panocular
PAX6-related aniridia involves partial or severe iris hypoplasia but can also affect foveal development, cornea, lens, angle and optic nerve. Foveal hypoplasia and nystagmus may limit acuity before progressive cataract, glaucoma or keratopathy develops. Residual iris tissue can be present despite the name. Evaluate the entire eye and avoid attributing every visual limitation to glare from the iris defect.
Genetic assessment must consider whether a chromosome 11p13 deletion includes WT1 as well as PAX6, indicating WAGR spectrum and a need for tumour surveillance under an appropriate paediatric programme. Absence of a family history does not exclude this possibility. Not every isolated PAX6 variant carries the same Wilms tumour risk. The current GeneReviews PAX6 chapter distinguishes isolated disease from contiguous deletions and describes suitable testing strategies.
Aniridia-associated keratopathy reflects progressive limbal and surface dysfunction. A corneal graft alone does not correct limbal failure. Cataract or glaucoma surgery can be technically difficult because of tissue abnormalities and surface vulnerability. Plan interventions around the dominant reversible problem, explain the baseline developmental acuity limit and coordinate genetic and systemic care.
Other congenital findings and a clinical decision
A small cornea, large cornea, microphthalmia, coloboma or iris hypoplasia requires assessment of the globe rather than an isolated measurement label. Coloboma may involve iris, retina, choroid or nerve and can coexist with systemic syndromes. Persistent fetal vasculature can accompany lens and anterior abnormalities. An ocular prosthetic or cosmetic concern should not distract from visual-axis, glaucoma and amblyopia risks.
For an infant with bilateral iris hypoplasia and nystagmus, assess foveal structure and the rest of the eye, arrange genetic evaluation and identify systemic surveillance needs. For a unilateral central opacity with a clear peripheral window, determine whether fixation and optical rehabilitation are possible before proposing a graft. A complete answer explains both the developmental diagnosis and the interventions that preserve remaining visual potential.
Sections you finish are checked off in the contents.